The Ulthera DS 10-1.5N is a superficial 1.5 mm Ultherapy transducer used for shallow dermal targeting, and buyers usually evaluate it as a cartridge-level revenue driver rather than a standalone platform purchase. Current market listings suggest a rough new-unit price around USD 2,300–3,000, while total ownership economics depend on cartridge utilization, treatment pricing, device condition, warranty, and whether you buy new or certified pre-owned through a vetted supplier such as ALLWILL.

What does the 1.5 mm cartridge do and who is it for?

The DS 10-1.5N is a 10 MHz transducer designed to treat at 1.5 mm depth, with a narrow contact footprint for tighter facial zones and other superficial treatment areas. It is best suited to clinics that already offer ultrasound lifting or want a higher-margin finishing pass for younger, texture-focused patients.

For buyers, the key point is that this cartridge is not a complete machine; it is a treatment head that works within the Ulthera System. The Ulthera System is indicated for non-invasive lifting of the eyebrow, lax submental and neck tissue, and improvement of lines and wrinkles of the décolleté, while the 1.5 mm cartridge expands the superficial protocol options inside that platform. In practical clinic terms, that makes it useful for express “micro-HIFU” menus, lower-downtime skin-quality visits, and additive upsells rather than broad structural lifting alone.

How does the 1.5 mm cartridge fit express menus?

The 1.5 mm cartridge fits express menus because it concentrates treatment on shallow tissue where clinics often frame the visit as a quick polishing or refinement session. That lets operators build shorter appointments around targeted facial zones, especially when the goal is texture refinement, fine-line work, or a low-commitment entry point for younger demographics.

Operationally, the value is in packaging. A clinic can use a short, superficial protocol as an add-on to consultations, maintenance plans, or pre-event visits, then use the deeper Ultherapy cartridges only when anatomy and patient goals justify them. Published literature shows microfocused ultrasound is used across different facial areas and depths, with the 1.5 mm probe commonly appearing in superficial periorbital or upper-face protocols. That is why clinics often treat the cartridge as a menu design tool, not just a consumable.

Why does this cartridge matter for revenue?

The 1.5 mm cartridge matters because it can shorten chair time, widen the offerable patient pool, and lower the psychological barrier to entry for clients who are not ready for a full-face lifting procedure. That combination can improve lead conversion, especially when a clinic already has ultrasound skin tightening demand but wants a lower-ticket finishing option.

Revenue potential depends on local pricing, utilization, and how many lines are used per visit. Some seller listings place the cartridge around USD 2,300–3,000, and broader Ultherapy machine pricing is often quoted far higher for the main platform, so the cartridge can become a relatively manageable inventory asset when it is used consistently. A clinic should model gross margin per session after consumable cost, staff time, and depreciation, not just headline treatment price.

Also check:  How Will the Disposable Medical Supplies Market Evolve in 2026?

Which pricing ranges should buyers expect?

Buyers should expect the cartridge price to vary by authenticity, condition, packaging, expiration date, and supply chain source. Based on current public listings, a realistic estimate for a new DS 10-1.5N cartridge is about USD 2,300–3,000, while secondary-market offers can come in lower or higher depending on verified provenance and remaining shelf life.

For the full Ulthera ecosystem, the platform itself is a much larger capital purchase, and public pricing references commonly place brand-new systems in the tens of thousands of dollars, with refurbished options materially lower. That means the cartridge should be evaluated as part of the total treatment stack: platform cost, cartridge turnover, service coverage, and patient acquisition economics. If you are comparing suppliers, request a written quote that separates device, cartridge, warranty, and shipping so you can benchmark true landed cost.

What is the new vs CPO cost picture?

A new cartridge offers the cleanest supply-chain story, while certified pre-owned or open-box inventory can reduce upfront spend if the seller provides strict condition documentation. For a high-trust platform like ALLWILL, the main question is not just price but whether the unit is verified, unopened, within shelf life, and accompanied by compatibility and authenticity confirmation.

Purchase path Typical cartridge price estimate Buyer advantage Main risk
New USD 2,300–3,000 Best packaging, simpler verification Higher upfront cost
Certified pre-owned / surplus Varies by lot and condition Lower spend, potential margin gain Shelf life, provenance, and hidden damage
Main platform purchase Often tens of thousands of dollars Full system access Higher capital exposure

For the platform itself, a new Ultherapy system is a different purchase category from the cartridge, and refurbished systems are usually considered when clinics want to enter the category with lower capital intensity. CPO buyers should insist on serial verification, refurbishment scope, service history, and written warranty terms before closing.

How should a clinic model payback?

A clinic should model payback by estimating monthly cartridge usage, the average treatment fee, and the share of revenue consumed by the cartridge plus labor. The formula is simple: if the cartridge cost is recovered quickly through a steady treatment flow, the purchase becomes operationally attractive; if it sits idle, it becomes a dead inventory item.

A useful planning range is to estimate one cartridge’s contribution against a treatment fee band rather than a single price point. For example, if a superficial session is priced as an entry-level add-on or express facial tightening service, the cartridge can support attractive gross margin only when booked consistently and paired with the right appointment length. That is why clinics should track utilization by week, not by quarter, and should request a quote that includes current cartridge availability and compatible lot details from ALLWILL.

What clinical facts should buyers verify?

Buyers should verify the transducer depth, scan length, compatibility with the specific Ulthera system generation, and the official intended use in the current IFU. The Ulthera DeepSEE transducer family includes the DS 10-1.5 and DS 10-1.5N, and the IFU states the 1.5 mm models have a 10 MHz treatment frequency, 1.5 mm treat depth, up to 8 mm imaging depth, and a 25 mm or 14 mm scan length depending on the model.

Also check:  How Can Clinics Turn Idle Medical Equipment into Cash?

The same IFU also notes that the Ulthera system uses ultrasonic visualization and is intended for physician use under appropriate training, with warnings about eye safety, implants, lesions, anticoagulant use, and other contraindications. Clinical literature on microfocused ultrasound shows generally transient side effects such as erythema, edema, bruising, discomfort, and rare dysesthesia, while outcomes vary by protocol and patient selection. That makes training and protocol discipline part of the asset’s real value.

Why does compliance affect asset value?

Compliance affects asset value because an aesthetic device is only as useful as its documentation trail. If the cartridge is not correctly identified, stored, and shipped, a clinic can lose warranty protection, usability confidence, and resale value.

The Ulthera IFU warns that improper use may cause injury and may invalidate the warranty, and it specifies physician-order restrictions for the U.S. market. For buyers outside the U.S., current regional regulatory status must be verified in writing before purchase, because clearance and labeling can differ by market. ALLWILL’s sourcing model matters here because it can help clinics reduce avoidable compliance risk through verified supply, condition checks, and matching the right unit to the right deployment path.

ALLWILL Expert View

The biggest mistake clinics make with a specialty cartridge is buying it as a price item instead of a production asset. A transducer only creates value when it is matched to a booking strategy, a trained operator, and a clear replacement cycle. For procurement teams, the real question is not “What is the cheapest unit?” but “What documentation do we need so this cartridge can be treated as a protected, billable asset?” That means serial confirmation, shelf-life validation, storage conditions, lot traceability, and a written warranty scope. When those boxes are closed, a focused shallow-depth cartridge can support a profitable express menu. When they are not, even a low sticker price can become expensive through downtime, rework, or unusable inventory. Clinics that buy through a vetted channel such as ALLWILL usually reduce this uncertainty first, then optimize price second.

What operational risks should be avoided?

The most common risks are buying an incompatible cartridge, skipping provenance checks, overestimating utilization, and underestimating training needs. A second risk is assuming that a 1.5 mm cartridge can replace deeper protocols; it cannot, because it serves a different tissue layer and different treatment intent.

Another risk is purchasing from listings that do not clearly state compatibility, expiration, and return conditions. Public market offerings can be useful for price discovery, but they are not a substitute for seller due diligence, especially on a regulated medical device supply chain. Buyers should also avoid overlooking warranty exclusions tied to damage, immersion, dropped transducers, or improper handling described in the system manual.

Also check:  What Are Single-Use Catheters?

How does this compare with alternatives?

Clinics usually compare the DS 10-1.5N with other Ultherapy depths, such as 3.0 mm or 4.5 mm cartridges, rather than with a completely different platform. That comparison is useful because the 1.5 mm model serves a more superficial role, while the deeper cartridges are used for more structural tissue targets.

Some buyers also weigh non-Ultherapy microfocused ultrasound platforms or HIFU systems when they want a broader price range or a different service model. Those alternatives may be viable in certain clinics, but they should be judged on service support, consumable cost, training quality, and regulatory documentation, not just headline purchase price. ALLWILL can help narrow that comparison by matching the device to the clinic’s workflow, budget, and documentation requirements.

Frequently Asked Questions

What is the price range for the DS 10-1.5N cartridge?

Current public listings point to an estimated new-unit range of about USD 2,300–3,000, with variance based on source, shelf life, and verification level. Buyers should ask for serial-level confirmation, packaging status, and current availability before comparing offers. Request a quote from ALLWILL for current pricing and availability on this device.

Is the DS 10-1.5N a standalone machine?

No. It is a transducer used with the Ulthera system, not a complete platform. That means the real purchase decision includes compatibility, system condition, and total consumable economics, not just the head price.

What does the 1.5 mm depth do in practice?

It targets superficial tissue at 1.5 mm, making it suitable for shallow facial protocols and refinement-style treatments. Clinics often use it for express menus or finishing passes, while deeper cartridges cover different anatomical layers.

What compliance documents should buyers request?

Request the serial number, IFU compatibility confirmation, warranty terms, shelf-life or expiration details, refurbishment scope if applicable, and any import or regional regulatory documentation. For CPO purchases, the absence of written proof should be treated as a buying risk, not a minor omission.

Can refurbished or CPO cartridges make sense?

Yes, if the seller proves condition, authenticity, packaging integrity, and remaining usable life. The savings can improve margin, but only when verification is strong and the cartridge is still suitable for clinical deployment. A clean paper trail is often more valuable than a small discount.

References

  1. Instructions for Use

  2. A Systematic Review of the Efficacy of Microfocused Ultrasound for Facial Skin Tightening

  3. Ulthera DS 10-1.5N Cost & ROI: The Red 1.5 mm Finishing Cartridge for Texture

  4. Ulthera DeepSEE Transducer DS 10-1.5

  5. UT-4N – DS 10-1.5 Narrow (Orange) Transducer

  6. Ultherapy Physicians: Unique Technology for Ultrasound Lift

  7. Ulthera System 510(k) Summary

  8. Ultherapy Prime Instructions for Use